1.
Şimşek T, Yılmaz A, Erdoğan G, Peştereli E. Histopathological Efficacy of Docetaxel Versus Paclitaxel As First Line Chemotherapy for Epithelial Ovarian Carcinoma. Gynecol Obstet Reprod Med [Internet]. 2008Dec.27 [cited 2024Apr.19];14(3):189-92. Available from: https://www.gorm.com.tr/index.php/GORM/article/view/470